相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Emerging vaccine nanotechnology: From defense against infection to sniping cancer
Chan Feng et al.
Acta Pharmaceutica Sinica B (2022)
Bioinspired magnetic nanocomplexes amplifying STING activation of tumor-associated macrophages to potentiate cancer immunotherapy
Tianliang Li et al.
NANO TODAY (2022)
Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
Jiayi Ye et al.
ACTA PHARMACEUTICA SINICA B (2022)
Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition
Jing Gao et al.
CHINESE CHEMICAL LETTERS (2021)
Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
Golnaz Morad et al.
CELL (2021)
Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer
Fang Sun et al.
ADVANCED SCIENCE (2021)
Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
Fengqi Zhou et al.
NANO TODAY (2021)
Broadening horizons: the role of ferroptosis in cancer
Xin Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Engineering Oxaliplatin Prodrug Nanoparticles for Second Near-Infrared Fluorescence Imaging-Guided Immunotherapy of Colorectal Cancer
Qiurong Zhu et al.
SMALL (2021)
Endogenous Stimuli-Activatable Nanomedicine for Immune Theranostics for Cancer
Weiqi Wang et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer
Milena Hornburg et al.
CANCER CELL (2021)
Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD-L1 Expression for Circumventing Immune Resistance of Cancer
Fengqi Zhou et al.
ADVANCED MATERIALS (2021)
Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer
Rundi Song et al.
ADVANCED MATERIALS (2021)
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
Madiha Saeed et al.
ADVANCED MATERIALS (2021)
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala et al.
NATURE REVIEWS CANCER (2021)
Engineering Stimuli-Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy
Bo Hou et al.
ADVANCED MATERIALS (2020)
Dynamic covalent chemistry-regulated stimuli-activatable drug delivery systems for improved cancer therapy
Qiwen Zhu et al.
CHINESE CHEMICAL LETTERS (2020)
Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer
Ang Gao et al.
NANO LETTERS (2020)
Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
Jing Gao et al.
ACTA PHARMACOLOGICA SINICA (2020)
Supramolecular Prodrug Nanovectors for Active Tumor Targeting and Combination Immunotherapy of Colorectal Cancer
Xianli Hu et al.
ADVANCED SCIENCE (2020)
Engineering Prodrug Nanomedicine for Cancer Immunotherapy
Bin Yang et al.
ADVANCED SCIENCE (2020)
Triangle-Shaped Tellurium Nanostars Potentiate Radiotherapy by Boosting Checkpoint Blockade Immunotherapy
Wei Huang et al.
MATTER (2020)
Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer
Melanie Desbois et al.
NATURE COMMUNICATIONS (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
Engineering nanoparticles to locally activate T cells in the tumor microenvironment
Dangge Wang et al.
SCIENCE IMMUNOLOGY (2019)
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Chen Liang et al.
ADVANCED MATERIALS (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
Fangyuan Zhou et al.
ADVANCED MATERIALS (2019)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Zheyu Shen et al.
ADVANCED MATERIALS (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Inhibition of TGFβ enhances immune-checkpoint blockade
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The Cancer Immunotherapy Revolution
Priscilla N. Kelly
SCIENCE (2018)
Intracellularly Acid-Switchable Multifunctional Micelles for Combinational Photo/Chemotherapy of the Drug-Resistant Tumor
Tingting Wang et al.
ACS NANO (2016)
Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade Enhanced Cancer Photodynamic Immunotherapy
Dangge Wang et al.
NANO LETTERS (2016)
Classifying Cancers Based on T-cell Infiltration and PD-L1
Michele W. L. Teng et al.
CANCER RESEARCH (2015)
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Ulrich Laechelt et al.
CHEMICAL REVIEWS (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
CANCER DISCOVERY (2015)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Regulatory T Cells: Mechanisms of Differentiation and Function
Steven Z. Josefowicz et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Jacques Neefjes et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Progress and problems with the use of viral vectors for gene therapy
CE Thomas et al.
NATURE REVIEWS GENETICS (2003)